Breeksema, Joost J. http://orcid.org/0000-0002-8787-4610
Niemeijer, Alistair
Kuin, Bouwe
Veraart, Jolien
Vermetten, Eric
Kamphuis, Jeanine
van den Brink, Wim
Schoevers, Robert
Article History
Received: 13 March 2023
Accepted: 12 May 2023
First Online: 24 May 2023
Declarations
:
: RS received two research grants from the Netherlands Organization Health Research and Development (ZonMW) for clinical studies on oral esketamine and is co-investigator of a clinical study on psilocybin funded by Compass Pathways and a study on treatment-resistant depression funded by Novartis. He received an educational grant from Janssen, Pharmaceutical Companies of Johnson and Johnson, and honoraria from Clexio Biosciences and GH Research. EV is the principal investigator of a clinical trial on MDMA funded by the Multidisciplinary Association for Psychedelic Studies. WvdB has been a consultant for Janssen Netherlands and is a member of the Scientific Advisory Board of Clearmind. JJB, AN, BK, JV, and JK declare no conflicts of interest.